BE523903A - - Google Patents
Info
- Publication number
- BE523903A BE523903A BE523903DA BE523903A BE 523903 A BE523903 A BE 523903A BE 523903D A BE523903D A BE 523903DA BE 523903 A BE523903 A BE 523903A
- Authority
- BE
- Belgium
- Prior art keywords
- piperazine
- boiling point
- base
- residue
- products
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- NWVNXDKZIQLBNM-UHFFFAOYSA-N Diphenylmethylpiperazine Chemical class C1CNCCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 NWVNXDKZIQLBNM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052801 chlorine Chemical group 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- -1 2-hydroxyethoxy Chemical group 0.000 description 1
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical class [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- AKOBQWDMLNGRHM-UHFFFAOYSA-N ClC1=CC=C(C(C2=CC=CC=C2)N2CCN(CC2)CCCO)C=C1 Chemical compound ClC1=CC=C(C(C2=CC=CC=C2)N2CCN(CC2)CCCO)C=C1 AKOBQWDMLNGRHM-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 230000001376 precipitating Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001187 sodium carbonate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940066771 systemic antihistamines Piperazine derivatives Drugs 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE523903A true BE523903A (fi) |
Family
ID=158695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE523903D BE523903A (fi) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE523903A (fi) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0144991A2 (en) * | 1983-12-10 | 1985-06-19 | Wako Pure Chemical Industries, Ltd. | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives |
-
0
- BE BE523903D patent/BE523903A/fr unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0144991A2 (en) * | 1983-12-10 | 1985-06-19 | Wako Pure Chemical Industries, Ltd. | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives |
| EP0144991A3 (en) * | 1983-12-10 | 1985-07-17 | Wako Pure Chemical Industries, Ltd. | Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0005142A1 (de) | Phenylpiperazinderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte hierfür und Arzneimittel enthaltend solche Phenylpiperazinderivate | |
| FR2460919A1 (fr) | Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique | |
| FR2549059A1 (fr) | Procede de preparation de 1-pyridyl-alkyl-4-aryl-piperazines, leur separation en les antipodes optiques (enantiomorphes) respectifs et les stereo-isomeres ainsi obtenus | |
| EP0206173A1 (en) | Production of dibromonitro compound | |
| BE523903A (fi) | ||
| EP0173597A1 (fr) | Nouveaux éther-oxydes dérivés de cyclopropylphénols | |
| CH642614A5 (fr) | Procede de preparation d'acides trichlorophenoxyalcanoiques et de leurs derives exempts de dibenzo-p-dioxines chlorees. | |
| BE523900A (fi) | ||
| CH322820A (fr) | Procédé de préparation de N-monobenzhydryl-pipérazines substituées | |
| BE523899A (fi) | ||
| BE549420A (fi) | ||
| BE523901A (fi) | ||
| BE523902A (fi) | ||
| CH322817A (fr) | Procédé de préparation de dérivés la pipérazine | |
| CH322816A (fr) | Procédé de préparation de dérivés de la N-mono-benzhydryl-pipérazine | |
| CH322819A (fr) | Procédé de préparation d'éthers de la N-mono-benzhydryl-pipérazine | |
| CH365381A (fr) | Procédé pour la préparation de dérivés de la pipérazine | |
| CH354085A (fr) | Procédé de préparation de pipérazines | |
| BE475031A (fi) | ||
| BE530795A (fi) | ||
| CH364508A (fr) | Procédé de préparation de phénosélénazines substituées | |
| CH361572A (fr) | Procédé de préparation de pipérazines | |
| CH353743A (fr) | Procédé de préparation de pipérazines | |
| CH350296A (fr) | Procédé de préparation de N-(o-halogéno-phenyl)-pipérazines N'-alcoylées | |
| BE500675A (fi) |